Filing metadata

Accession number
0001567619-22-001444
Form type
Form 3
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Jan 21, 2022
Reporting period
Jan 11, 2022
Description
Initial ownership

Explore SEC Filings Hub